EDTUTC-4 New YorkLog in Sign up

FDMT
4D Molecular Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:56 PM EDT

13.69USD-1.084%(-0.15)1,036,924

Pre-marketOct 2, 2026 9:25:30 AM EDT

14.00USD+1.156%(+0.16)

After-hoursOct 2, 2026 4:26:30 PM EDT

13.67USD-0.146%(-0.02)

FDMT News

Day breaks

10:25 AM EDT4DMT Molecular enters phase 3 trial of 4D-150 for diabetic eye disease ·

Seeking Alpha

08:00 AM EDT4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME ·

GlobeNewswire Inc.

10:48 AM EDT4D Molecular Therapeutics, Inc. (FDMT) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript ·

Seeking Alpha

10:01 PM EDT4D Molecular Therapeutics, Inc. (FDMT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha

08:00 AM EDT4DMT to Participate in Upcoming Investor Conferences ·

GlobeNewswire Inc.